R1 RCM Inc

R1 RCM — Q1 2023 Earnings Presentation

9 slides from R1 RCM's earnings presentation, May 4, 2023

  1. Slide 1: First Quarter 2023 Earnings Call

    May 4, 2023 First Quarter 2023 Earnings Call Exhibit 99.2

  2. Slide 2: Forward-Looking Statements

    22 Forward-Looking Statements This presentation includes information that may constitute “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-lookin

  3. Slide 3: First Quarter Results and Key Themes

    33 First Quarter Results and Key Themes First Quarter 2023 Results Note1: Adjusted EBITDA is a non-GAAP measure; refer to the Appendix for reconciliation of non-GAAP financial measures • Revenue of $545.6 million, up $159.9 million or 41.5% compared to the same period last year • GAAP net income of

  4. Slide 4: Today's Discussion Topics: Q1 Updates

    44 Today's Discussion Topics: Q1 Updates Operational Performance • Automation use cases continue to expand; continued progress integrating Cloudmed capabilities into R1's ecosystem • Enhanced Optimal Workflow Initiative to focus on efficiency for work that cannot be automated • Deployed new machine

  5. Slide 5: 1Q'23 Non-GAAP Results – Q/Q and Y/Y Comparison

    55 1Q'23 Non-GAAP Results – Q/Q and Y/Y Comparison ($ in millions) 1Q'23 4Q'22 1Q'22 Key change driver(s) Revenue $545.6 $532.8 $385.7 • Q/Q: Contribution from onboarding of new customers • Y/Y: Contribution from Cloudmed and new customers Adjusted Cost of Services1 $362.2 $364.5 $273.6 • Q/Q: Cost

  6. Slide 6: Additional Commentary

    66 Additional Commentary Cash Flow and Balance Sheet Highlights • Reaffirming 2023 guidance • Revenue of $2,280 million to $2,330 million • GAAP operating income of $115 million to $140 million • Adjusted EBITDA1 of $595 million to $630 million • Expect Q2 2023 adjusted EBITDA1 approximately in line

  7. Slide 7: Appendix

    endix p Ap ) ol

  8. Slide 8: Use of Non-GAAP Financial Measures

    88 Use of Non-GAAP Financial Measures Reconciliation of GAAP Operating Income Guidance to Non-GAAP Adjusted EBITDA Guidance $ in millions  In order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company

  9. Slide 9: Reconciliation of Non-GAAP Financial Measures

    99 Reconciliation of Non-GAAP Financial Measures Reconciliation of GAAP SG&A to Non-GAAP SG&A Reconciliation of GAAP Cost of Services to Non-GAAP Cost of Services Note1: For details see Note 8, Other, to the consolidated financial statements included in the Company’s quarterly report of Form 10-Q Th

R1 RCM — Q1 2023 Earnings Presentation on 6ix